LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Carlo Montagner, president of Abraxis Oncology, the company’s proprietary products division, will present a company overview at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference on Thursday, April 12, 2007 at 3:05 p.m. EDT at the Millennium Broadway Hotel in New York City.
